GB

Nagaraja K Rao

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagaraja K Rao. Retrieved from https://idiyas.com/inventor/nagaraja-k-rao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Nagaraja K Rao: Innovator in Pharmaceutical Research

Introduction

Nagaraja K Rao is a notable inventor based in Great Britain. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for treating various diseases. His work focuses on innovative methods and compositions that address critical health issues.

Latest Patents

Nagaraja K Rao holds several patents, including:

1. **Methylphenidate Derivatives And Their Use In The Treatment Of Angiogenic Diseases And Conditions** - This invention provides methods for using specific compounds and their derivatives to treat angiogenic diseases.

2. **Method Of Using Diketopiperazines And Composition Containing Them** - This patent outlines a method for inhibiting the effects of platelet activating factor (PAF), particularly in conditions mediated by inflammation. It also discusses the inhibition of interleukin 8 (IL-8) production by cells.

Career Highlights

Throughout his career, Nagaraja K Rao has worked with prominent companies in the pharmaceutical industry. He has been associated with Ampio Pharmaceuticals, Inc. and DMI Biosciences, Inc. These experiences have allowed him to contribute to significant advancements in drug development.

Collaborations

Nagaraja K Rao has collaborated with esteemed professionals in his field, including David Bar-Or and C Gerald Curtis. These partnerships have enhanced his research and innovation efforts.

Conclusion

Nagaraja K Rao is a dedicated inventor whose work in pharmaceutical research has the potential to impact the treatment of various diseases. His innovative approaches and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…